Litigation Details for Eli Lilly and Company v. Teva Pharmaceuticals USA Inc (W.D. Wash. 2017)

✉ Email this page to a colleague

Docket	⤷ Sign Up	Date Filed	2017-02-01
Court	District Court, W.D. Washington	Date Terminated	2020-02-20
Cause	00:0000 Cause Code Unknown	Assigned To	James L. Robart
Jury Demand	None	Referred To
Patents	6,943,166
Link to Docket	External link to docket

The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
2017-02-01	1	Motion to Quash	17 Decl. at ¶ 3.) The patent-in-suit—U.S. Patent No. 6,943,166 (“’166 patent”)—is entitled 18 “Compositions…named co-inventor 23 of the ’166 patent. (See Dkt. No. 1-1, ’166 Patent at Cover Page; Stewart Decl. at…contemplation of filing a patent 12 application or other document with the [Patent and Trademark] Office…corporation’s patent attorney that an invention has been made and to initiate patent action.” In re…discoverable in a patent case, if those materials relate to an issue of substantive patent law.” Advanced	External link to document
2017-03-16	7	Order on Motion to Quash	U.S. Patent No. 6,943,166 (“the ’166 patent”). (Id.) Dr. Whitaker is 9 not a party to the Underlying…Plaintiffs assert a patent covering technology related to the drug Cialis. (Id.) 8 The patent-in-suit is U.S…a range of subjects, including the ’166 patent, a ’958 patent, research 21 related to the treatment…but he is “a named co-inventor of the ’166 10 patent” (id.) and a former employee of ICOS, which Lilly… confidential information includes “unpublished patent applications, investigational new 10 drug applications	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document